Lanean...
The next generation BET inhibitor, PLX51107, delays melanoma growth in a CD8-mediated manner
Epigenetic agents such as bromodomain and extra terminal region inhibitors (BETi) slow tumor growth via tumor intrinsic alterations; however, their effects on anti-tumor immunity remain unclear. A recent advance is the development of next generation BETi that are potent and display a favorable half-...
Gorde:
| Argitaratua izan da: | Pigment Cell Melanoma Res |
|---|---|
| Egile Nagusiak: | , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6697571/ https://ncbi.nlm.nih.gov/pubmed/31063649 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/pcmr.12788 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|